p16 protein variant and use thereof for preventing or treating cancer
    2.
    发明授权
    p16 protein variant and use thereof for preventing or treating cancer 有权
    p16蛋白质变体及其用于预防或治疗癌症的用途

    公开(公告)号:US09573985B2

    公开(公告)日:2017-02-21

    申请号:US14615146

    申请日:2015-02-05

    CPC classification number: C07K14/4738 A61K38/00

    Abstract: A p16 protein variant; a polynucleotide encoding the p16 protein variant; a method for preparing the p16 protein variant; a pharmaceutical composition comprising the p16 protein variant; a method for preventing and/or treating cancer comprising administering the p16 protein variant to a subject; and use of the p16 protein variant in the prophylaxis and/or therapy of cancer.

    Abstract translation: p16蛋白变体; 编码p16蛋白质变体的多核苷酸; 制备p16蛋白质变体的方法; 包含p16蛋白质变体的药物组合物; 一种用于预防和/或治疗癌症的方法,其包括将p16蛋白质变体施用于受试者; 以及在预防和/或治疗癌症中使用p16蛋白质变体。

    STORAGE DEVICE ALLOCATING UNIT ZONE REGIONS, AND METHOD OF OPERATING THE SAME

    公开(公告)号:US20240370188A1

    公开(公告)日:2024-11-07

    申请号:US18542119

    申请日:2023-12-15

    Abstract: A method of operating a storage device which communicates with a host device includes allocating a plurality of unit zone regions each having a unit zone size, each of the plurality of unit zone regions being mapped to at least one corresponding memory blocks among a plurality of memory blocks in the storage device and supporting a sequential write in compliance with a zoned namespace (ZNS) standard, receiving a first request indicating an allocation operation of a first zoned namespace in compliance with the ZNS standard from the host device, determining a first mapping ratio by dividing a first zone size of the first zoned namespace by the unit zone size, based on the first request, and storing the first mapping ratio in a zone metadata table of the storage device.

    P15 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER
    4.
    发明申请
    P15 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER 有权
    P15蛋白变异及其用于预防或治疗癌症的方法

    公开(公告)号:US20150218243A1

    公开(公告)日:2015-08-06

    申请号:US14615224

    申请日:2015-02-05

    CPC classification number: C07K14/4738 A61K38/00 C07K14/4703

    Abstract: A p15 protein variant; a polynucleotide encoding the p15 protein variant; a method for preparing the p15 protein variant; a pharmaceutical composition comprising the p15 protein variant; and a method for preventing and/or treating cancer comprising administering the p15 protein variant to a subject.

    Abstract translation: p15蛋白质变体; 编码p15蛋白变体的多核苷酸; 制备p15蛋白变体的方法; 包含该p15蛋白质变体的药物组合物; 以及用于预防和/或治疗癌症的方法,其包括将p15蛋白质变体施用于受试者。

    p16 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER
    5.
    发明申请
    p16 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER 有权
    p16蛋白变异及其用于预防或治疗癌症的方法

    公开(公告)号:US20150218240A1

    公开(公告)日:2015-08-06

    申请号:US14615146

    申请日:2015-02-05

    CPC classification number: C07K14/4738 A61K38/00

    Abstract: A p16 protein variant; a polynucleotide encoding the p16 protein variant; a method for preparing the p16 protein variant; a pharmaceutical composition comprising the p16 protein variant; a method for preventing and/or treating cancer comprising administering the p16 protein variant to a subject; and use of the p16 protein variant in the prophylaxis and/or therapy of cancer.

    Abstract translation: p16蛋白变体; 编码p16蛋白质变体的多核苷酸; 制备p16蛋白质变体的方法; 包含p16蛋白质变体的药物组合物; 一种用于预防和/或治疗癌症的方法,其包括将p16蛋白质变体施用于受试者; 以及在预防和/或治疗癌症中使用p16蛋白质变体。

    P15 protein variant and use thereof for preventing or treating cancer
    7.
    发明授权
    P15 protein variant and use thereof for preventing or treating cancer 有权
    P15蛋白质变体及其用于预防或治疗癌症的用途

    公开(公告)号:US09512193B2

    公开(公告)日:2016-12-06

    申请号:US14615224

    申请日:2015-02-05

    CPC classification number: C07K14/4738 A61K38/00 C07K14/4703

    Abstract: A p15 protein variant; a polynucleotide encoding the p15 protein variant; a method for preparing the p15 protein variant; a pharmaceutical composition comprising the p15 protein variant; and a method for preventing and/or treating cancer comprising administering the p15 protein variant to a subject.

    Abstract translation: p15蛋白质变体; 编码p15蛋白变体的多核苷酸; 制备p15蛋白变体的方法; 包含该p15蛋白质变体的药物组合物; 以及用于预防和/或治疗癌症的方法,其包括将p15蛋白质变体施用于受试者。

Patent Agency Ranking